Abstract
Mucus hypersecretion is a major pathophysiologic feature in chronic inflammatory airway diseases. Oxidative stress plays a pivotal role in this process. Recent studies have found that heparin has antioxidant effects which can reduce free radical damage. Here, we hypothesized that heparin has some influence on the expression of mucin 5AC (MUC5AC) induced by phorbol myristate acetate (PMA) in a bronchial epithelial cell line (HBE16), also we have investigated the potential mechanism involved in the process. We found that ROS, the mRNA of Duox1, EGFR and MUC5AC, as well as the protein levels of Duox1, p-EGFR, EGFR, and MUC5AC in the PMA group were significantly increased when compared with the control group (all P < 0.01). After pretreatment with heparin however, there was a significant decrease in ROS levels, the mRNA of Duox1, EGFR, and MUC5AC, and the protein levels of Duox1, p-EGFR, EGFR, and MUC5AC, when compared with the PMA group (all P < 0.01). MUC5AC protein in the supernatant was inhibited in a dose-dependent manner by heparin. Pretreatment with DMTU resulted in a significant decrease in ROS content, the mRNA of Duox1, EGFR, and MUC5AC as well as the protein levels of Duox1, p-EGFR, EGFR, and MUC5AC when compared with the PMA group (all P < 0.01). When cells were pretreated with both heparin and DMTU, there was a further reduction in ROS content, the mRNA of Duox1, EGFR, and MUC5AC as well as the protein levels of Duox1, p-EGFR, EGFR, and MUC5AC, when compared with either the PMA group, heparin group, or DMTU group (all P < 0.01). Our results show that PMA can induce MUC5AC expression by activation of the Duox1-ROS-TACE-TGF-α-EGFR signaling pathway. Heparin can decrease the level of Duox1, ROS production and block the PMA-induced activation of EGFR, thus inhibiting the overexpression of mucin MUC5AC in a dose-dependent manner. In addition to reducing ROS production, heparin may also inhibit the expression of MUC5AC through other signal mechanisms.
Similar content being viewed by others
Abbreviations
- DMTU:
-
Dimethylthiourea
- Duox1:
-
Dual oxidase 1
- EGFR:
-
Epidermal growth factor receptor
- HNE:
-
Human neutrophil elastase
- MUC5AC:
-
Mucin 5AC
- PMA:
-
Phorbol myristate acetate
References
Vovnow JA (2002) What dose mucin have to do with lung disease. J Paediatr Respir Rev 3:98–103
Hovenberg HW, Davies JR, Herrmann A, Lindén CJ, Carlstedt I (1996) MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. J Glycoconj 13:839–847
Rose MC, Kaufman B, Martin BM (1989) Proteolytic fragmentation and peptide mapping of human carboxyamidomethylated tracheobronchial mucin. J Biol Chem 264:8193–8199
Burgel PR, Nadel JA (2004) Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. J Thorax 59:992–996
Takeyama K, Dabbagh K, Lee HM, Agustí C, Lausier JA, Ueki IF, Grattan KM, Nadel JA (1999) Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 96:3081–3086
Oyarzun-Ampuero FA, Brea J, Loza MI, Torres D, Alonso MJ (2009) Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int J Pharm 381:122–129
Brown RA, Allegra L, Matera MG, Page CP, Cazzola M (2006) Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. Pulm Pharmacol Ther 19:419–424
Hunter T, Cooper JA (1981) Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell 24:741–752
Rosette C, Karin M (1996) Ultraviolet light and osmotic stress: activation of the JNK cascade. Science 274:1194–1197
Gamou S, Shimizu N (1995) Hydrogen peroxide preferentially enhances the tyrosine phosphorylation. FEBS Lett 357:161–164
Goldkorn T, Balaban N, Matsukuma K, Chea V, Gould R, Last J, Chan C, Chavez C (1998) EGF-receptor phosphorylation and signaling are targeted by H2O2 redox. Am J Respir Cell Mol Biol 19:786–798
Daub H, Weiss FU, Wallasch C, Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein. Nature 379:557–560
Tsai W, Morielli AD, Peralta EG (1997) The m1 muscarinic acetylcholine receptor transactivates the EGF. J EMBO 16:4597–4605
Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H et al (1997) Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390:91–96
Forteza R, Salathe M, Miot F, Forteza R, Conner GE (2005) Regulated hydrogen peroxide production by Duox in human airway epithelial cells. J Am J Respir Cell Mol Biol 32:462–469
Shao MX, Nadel JA (2005) Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. J Proc Natl Acad Sci USA 102:767–772
Li Q, Zhou XD, Nie XH, Yang J (2010) The role of recombinant human elafin in the resistance of A549 cells against Pseudomonas aeruginosa biofilm. Respiration 79:68–75
Hewson CA, Edbrooke MR, Johnston SL (2004) PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf MEK, ERK and Sp1-dependent mechanisms. J Mol Biol 344:683–695
Li Q, Zhou XD, Yu HM, Nie XH, Xu XY (2010) Regulation of neutrophil elastase-induced MUC5AC expression by Nrf2 in human airway epithelial cells. J Investig Med 58:730–736
Takeyama K, Dabbagh K, Shim JJ, Dao-Pick T, Ueki IF, Nadel JA (2000) Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 164:1546–1552
Tyrrell DJ, Horne AP, Holme KR, Preuss JM, Page CP (1999) Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol 46:151–208
Davidson BL, Geerts WH, Lensing AW (2002) Low-dose heparin for severe sepsis. N Engl J Med 347:1036–1037
Day R, Forbes A (1999) Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet 354:62–65
Hoppensteadt D, Fareed J, Klein AL, Jasper SE, Apperson-Hansen C, Lieber EA, Katz WE, Malouf JF, Stoddard MF, Pape LA (2008) Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation. Am J Cardiol 102:842–846
Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, Adachi R, Gurish MF, Gobezie R, Stevens RL et al (2009) Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 182:647–656
Ahmed T, Garrigo J, Danta I (1993) Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N Engl J Med 329:90–95
Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Papageorgiou A, Vassiliadis T, Giouleme O, Evgenidis N (2006) Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther 23:1443–1453
Saliba MJ Jr (2001) Heparin in the treatment of burns: a review. Burns 27:349–558
Hochart H, Jenkins PV, Smith OP, White B (2006) Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes. Br J Haematol 133:62–67
Brown RA, Lever R, Jones NA, Page CP (2003) Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. Br J Pharmacol 139:845–853
Acknowledgments
This study was supported by grant from the National Nature Science Foundation of China (No. 81070031), and China–Russia Cooperation Research Foundation (No. 81011120108). There are no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Q., Lei, R.X., Zhou, X.D. et al. Regulation of PMA-induced MUC5AC expression by heparin in human bronchial epithelial cells. Mol Cell Biochem 360, 383–391 (2012). https://doi.org/10.1007/s11010-011-1078-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-1078-9